Individuals with androgenetic alopecia face an increased risk of depression, with an odds ratio of 1.015, according to a new Mendelian randomization study.
The FDA has approved tenecteplase for acute ischemic stroke, offering a faster and simpler administration compared to alteplase based on findings from the AcT trial.
Dolutegravir led to faster virologic suppression and lower virologic failure rates than standard care, according to the ODYSSEY trial's latest analysis.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Anticholinergic bladder drugs were associated with an increased risk of dementia compared with nonuse, but not when compared with the beta-3 agonist mirabegron.